Anticancer agent 9

Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1].

Product Specifications

CAS Number

[592542-61-5]

UNSPSC

12352005

Hazard Statement

H302-H311-H314-H318-H401-H411

Target

Amino Acid Derivatives

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/anticancer-agent-9.html

Purity

96.58

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C(OC)CNC1=CC(CS(=O)(/C=C/C2=C(OC)C=C(OC)C=C2OC)=O)=CC=C1OC

Molecular Formula

C22H27NO8S

Molecular Weight

465.52

Precautions

P260-P264-P270-P273-P280-P301+P330+P331-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P330-P361+P364-P363-P391-P405-P501

References & Citations

[1]Pallela VR, et, al. Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z) -isomers of ON 01910•Na (Rigosertib®), a phase III clinical stage anti-cancer agent. Org Biomol Chem. 2013 Mar 28;11 (12) :1964-77.